|本期目录/Table of Contents|

[1]王多伟,Bikash Rai,王金淼,等.Twist基因对结肠癌细胞系侵袭转移能力影响的体外研究[J].天津医科大学学报,2017,23(06):510-515.
 WANG Duo-wei,Bikash Rai,WANG Jin-miao,et al.Research on the influence of Twist gene on invasion and metastasis of colon cancer cell lines in vitro[J].Journal of Tianjin Medical University,2017,23(06):510-515.
点击复制

Twist基因对结肠癌细胞系侵袭转移能力影响的体外研究(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
23卷
期数:
2017年06期
页码:
510-515
栏目:
基础医学
出版日期:
2017-11-20

文章信息/Info

Title:
Research on the influence of Twist gene on invasion and metastasis of colon cancer cell lines in vitro
文章编号:
1006-8147(2017)06-0510-06
作者:
王多伟1Bikash Rai12王金淼1戚 峰1刘 彤1
(1.天津医科大学总医院普通外科,天津 300052;2.北京和睦家医院外科,北京 100015)
Author(s):
WANG Duo-wei1 Bikash Rai12 WANG Jin-miao1 QI Feng1 LIU Tong1
( 1. Department of General Surgery, General Hospital, Tianjin Medical University, Tianjin 300052, China; 2. Department of Surgery, Beijing United Family Hospitol, Beijing 100015, China)
关键词:
twist基因上皮间质转化结肠癌质粒shRNA侵袭和转移
Keywords:
Twist gene epithelial-mesenchymal transition colon carcinoma plasmid shRNA invasion and metastasis

' target="_blank" rel="external"> LINE-HEIGHT: 150%">

分类号:
R735.3+5
DOI:
-
文献标志码:
A
摘要:
目的 探讨Twist基因在SW480、HCT116和HT29结肠癌细胞系上皮-间质转化(EMT)中的作用,明确其对恶性肿瘤侵袭转移能力的影响。方法:利用重组质粒pTracer-CMV/BSD-Twist 和pGenesil1.2-Twist-shRNA转染SW480、HT29和HCT116;流式细胞术检测转染率;Real time-PCR和Western blot检测Twist,E-cadherin和Vimentin转录及蛋白表达水平;Transwell实验检测细胞的迁移和侵袭能力。结果转染高表达Twist质粒后,各结肠癌细胞系中Twist和Vimentin表达水平显著升高(P<0.05),E-cadherin显著降低(P<0.05);转染低表达Twist质粒后,SW480和HT29中各指标均无显著变化(P>0.05),HCT116中Twist 和Vimentin表达水平显著降低(P<0.05),E-cadherin无显著变化(P>0.05);Transwell实验表明抑制HCT116细胞系Twist表达后,其侵袭和迁移能力明显减弱(P<0.01)。结论上调Twist表达可以促进EMT;抑制HCT116 中Twist表达能减弱结肠癌细胞的侵袭和转移能力。
Abstract:
Objective To explore the role of Twist gene in Epithelial-MesenchymalTransition (EMT) in SW480, HCT116 and HT29, and then study effect of Twist on invasion and metastasis of malignant tumors. Methods: Recombinant plasmids pTracer-CMV/BSD-Twist and pGenesil1.2-Twist-shRNA were used to transfect SW480, HCT116 and HT29. Transfection efficacy of the plasmid in each cell line was confirmed by flowcytometry. The mRNA transcription level and protein expression level of Twist, E-cadherin and Vimentin were detected by RT-PCR and western blot, respectively. The migration and invasive analysis was done by transwell assay. Results: After transfected by recombinant high-expressed twist plasmid, the mRNA and protein expression levels of Twist and Vimentin increased significantly (P<0.05), whereas E-cadherin was inhibited (P<0.05). After transfected by recombinant low-expressed twist plasmid, all the parameters in SW480 and HT29 cell lines were statistically insignificant (P>0.05), the mRNA and protein levels of Twist and Vimentin were prominently inhibited in HCT116 cell line (P<0.05) and the level of E-cadherin was not statistically significant (P>0.05). Significant reduction of invasion and migration was observed in Transwell assay after inhibiting the Twist expression in HCT116 cell line (P<0.01). Conclusions: Up-regulation of Twist gene expression can promote the EMT and inhibiting the Twist gene expression can lessen the migration and invasion of HCT116.

参考文献/References:

[1] Favoriti P, Carbone G, Greco M, et al. Worldwide burden of colorectal cancer: a review[J]. Updates Surg, 2016,68(1):7

[2] Costi R, Leonardi F, Zanoni D, et al. Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist[J]. World J Gastroenterol, 2014,20(24):7602

[3] Son H, Moon A. Epithelial-mesenchymal transition and cell invasion[J]. Toxicol Res, 2010,26(4):245

[4] Creighton C J, Gibbons D L, Kurie J M. The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective[J]. Cancer Manag Res, 2013,5:187

[5] Lee K W, Yeo S Y, Sung C O, et al. Twist1 is a key regulator of cancer-associated fibroblasts[J]. Cancer Res, 2015,75(1):73

[6] Zou H, Feng X, Cao J G. Twist in hepatocellular carcinoma: pathophysiology and therapeutics[J]. Hepatol Int, 2015,9(3):399

[7] Vesuna F, Bergman Y, Raman V. Genomic pathways modulated by Twist in breast cancer[J]. BMC Cancer, 2017,17(1):52.

[8] Zhuo X, Chang A, Huang C, et al. Expression of TWIST, an inducer of epithelial-mesenchymal transition, in nasopharyngeal carcinoma and its clinical significance[J]. Int J Clin Exp Pathol, 2014,7(12):8862

[9] Sun H X, Feng H, Song Y. [Expression of Twist and relation with epithelial-mesenchymal transition in oral squamous cell carcinoma][J]. Hua Xi Kou Qiang Yi Xue Za Zhi, 2015,33(5):534

[10] Chen T, You Y, Jiang H, et al. Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation and tumorigenesis[J]. J Cell Physiol, 2017. [Epub ahead of print]

[11] Ikeguchi M, Makino M, Kaibara N. Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma[J]. J Surg Oncol, 2001,77(3):201

[12] Liu C Y, Lin H H, Tang M J, et al. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation[J]. Oncotarget, 2015,6(18):15966

[13] Ansieau S, Bastid J, Doreau A, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence[J]. Cancer Cell, 2008,14(1):79

[14] Gao Y, Xuan X Y, Zhang H Y, et al. Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma[J]. Cell Biol Int, 2012,36(6):571

[15] Ru G Q, Wang H J, Xu W J, et al. Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis[J]. Pathol Oncol Res, 2011,17(2):341

相似文献/References:

[1]马博昭,王小东,王金淼,等.吡非尼酮抑制肿瘤相关成纤维细胞促进结肠癌细胞系HT29上皮间质转化的作用及机制[J].天津医科大学学报,2018,24(05):399.
 MA Bo-zhao,WANG Xiao-dong,WANG Jin-miao,et al.Effect and mechanism of pirfenidone on epithelial-mesenchymal transition induced by cancer-associated fibroblasts in HT29 colon cancer cell lines[J].Journal of Tianjin Medical University,2018,24(06):399.
[2]付真睿,盛 飞,张昌文,等.SOX6在膀胱癌发生发展中的作用及相关机制[J].天津医科大学学报,2019,25(04):373.
 FU Zhen-rui,SHENG Fei,ZHANG Chang-wen,et al.The characteristics of SOX6 in development of bladder cancer and relevant mechanism[J].Journal of Tianjin Medical University,2019,25(06):373.
[3]闫晓芳,谢 虹,汤 华.miR-3685通过靶向CTTN抑制宫颈癌细胞的迁移、侵袭及生长[J].天津医科大学学报,2020,26(01):8.
 YAN Xiao-fang,XIE Hong,TANG Hua.miR-3685 inhibits migration, invasion and growth of cervical cancer cells by targeting CTTN[J].Journal of Tianjin Medical University,2020,26(06):8.
[4]朱婷婷 综述,周旋 审校.ZIP4与肿瘤生物学行为的研究进展[J].天津医科大学学报,2020,26(02):183.
[5]李智慧,姚菲菲,王富霞.NFATc1对非小细胞肺癌细胞增殖、迁移和上皮间质转化的影响[J].天津医科大学学报,2021,27(05):477.
 LI Zhi-hui,YAO Fei-fei,WANG Fu-xia.Effects of NFATc1 on the proliferation, migration and epithelial-mesenchymal transition of non-small cell lung cancer[J].Journal of Tianjin Medical University,2021,27(06):477.

备注/Memo

备注/Memo:
基金项目天津医科大学总医院孵育基金项目(2YYFY2016021)

作者简介王多伟(1990-),男,硕士在读,研究方向:普通外科;

通信作者:戚峰, E-mail:qf@medmail.com.cn

更新日期/Last Update: 2017-11-14